Page 45 - 84_02

Akao T, Terachi T, et al. Clonal and chronological
genetic analysis of multifocal cancers of the bladder
and upper urinary tract. Cancer Res. 1998 Dec
15;58(24):5835-41.
7. Cottu PH, Asselah J, Lae M, Pierga JY, Dieras V,
Mignot L, et al. Intratumoral heterogeneity of
HER2/neu expression and its consequences for the
management of advanced breast cancer. Ann Oncol.
2008 Mar;19(3):595-7.
8. Boland CR, Sato J, Appelman HD, Bresalier RS,
Feinberg AP. Microallelotyping defines the sequence
and tempo of allelic losses at tumour suppressor gene
loci during colorectal cancer progression. Nat Med.
1995 Sep;1(9):902-9.
9. Navin N, Krasnitz A, Rodgers L, Cook K, Meth J,
Kendall J, et al. Inferring tumor progression from
genomic heterogeneity. Genome Res. 2010
Jan;20(1):68-80.
10. Teixeira MR, Pandis N, Bardi G, Andersen JA, Heim
S. Karyotypic comparisons of multiple tumorous and
macroscopically normal surrounding tissue samples
from patients with breast cancer. Cancer Res. 1996
Feb 15;56(4):855-9.
11. Klein CA. Parallel progression of primary tumours
and metastases. Nat Rev Cancer. 2009 Apr;9(4):302-
12.
12. Navin N, Kendall J, Troge J, Andrews P, Rodgers L,
McIndoo J, et al. Tumour evolution inferred by single-
cell sequencing. Nature. 2011 Apr 7;472(7341):90-4.
13. Anderson K, Lutz C, van Delft FW, Bateman CM,
Guo Y, Colman SM, et al. Genetic variegation of
clonal architecture and propagating cells in leukaemia.
Nature. 2011;469(7330):356-61.
14. Greenman C, Stephens P, Smith R, Dalgliesh GL,
Hunter C, Bignell G, et al. Patterns of somatic
mutation in human cancer genomes. Nature. 2007 Mar
8;446(7132):153-8.
15. Beroukhim R, Mermel CH, Porter D, Wei G,
Raychaudhuri S, Donovan J, et al. The landscape of
somatic copy-number alteration across human cancers.
Nature. 2010 Feb 18;463(7283):899-905.
16. Greaves MF, Maia AT, Wiemels JL, Ford AM.
Leukemia in twins: lessons in natural history. Blood.
2003 Oct 1;102(7):2321-33.
17. Park SY, Gonen M, Kim HJ, Michor F, Polyak K.
Cellular and genetic diversity in the progression of in
situ human breast carcinomas to an invasive
phenotype. J Clin Invest. 2010 Feb;120(2):636-44.
18. Shipitsin M, Campbell LL, Argani P, Weremowicz S,
Bloushtain-Qimron N, Yao J, et al. Molecular
definition of breast tumor heterogeneity. Cancer Cell.
2007 Mar;11(3):259-73.
19. Dick JE. Stem cell concepts renew cancer research.
Blood. 2008 Dec 15;112(13):4793-807.
20. Furth J, Strumia M. Studies on Transmissible
Lymphoid Leucemia of Mice. J Exp Med. 1931 Apr
160
Ruth M. Risueño
30;53(5):715-31.
21. Southam CM, Brunschwig A. Quantitative studies of
autotransplantation of human cancer. Preliminary
report. Cancer. 1961;14(5):971-8.
22. Kleinsmith LJ, Pierce GB, Jr. Multipotentiality of
Single Embryonal Carcinoma Cells. Cancer Res. 1964
Oct;24:1544-51.
23. Shimada H, Chatten J, Newton WA, Jr., Sachs N,
Hamoudi AB, Chiba T, et al. Histopathologic
prognostic factors in neuroblastic tumors: definition of
subtypes of ganglioneuroblastoma and an age-linked
classification of neuroblastomas. J Natl Cancer Inst.
1984 Aug;73(2):405-16.
24. Ogawa M, Fried J, Sakai Y, Strife A, Clarkson BD.
Studies of cellular proliferation in human leukemia.
VI. The proliferative activity, generation time, and
emergence time of neutrophilic granulocytes in
chronic granulocytic leukemia. Cancer. 1970
May;25(5):1031-49.
25. Bonnet D, Dick JE. Human acute myeloid leukemia is
organized as a hierarchy that originates from a
primitive hematopoietic cell. Nature medicine.
1997;3(7):730-7.
26. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang
T, Caceres-Cortes J, et al. A cell initiating human
acute myeloid leukaemia after transplantation into
SCID mice. Nature. 1994;367(6464):645-8.
27. Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ, Clarke MF. Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci U
S A. 2003;100(7):3983-8.
28. O'Brien CA, Pollett A, Gallinger S, Dick JE. A human
colon cancer cell capable of initiating tumour growth
in immunodeficient mice. Nature.
2007;445(7123):106-10.
29. Li C, Heidt DG, Dalerba P, Burant CF, Zhang L,
Adsay V, et al. Identification of pancreatic cancer
stem cells. Cancer research. 2007;67(3):1030-7.
30. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani
J, Hide T, et al. Identification of human brain tumour
initiating cells. Nature. 2004;432(7015):396-401.
31. Zhang S, Balch C, Chan MW, Lai H-C, Matei D,
Schilder JM, et al. Identification and characterization
of ovarian cancer-initiating cells from primary human
tumors. Cancer research. 2008;68(11):4311-20.
32. Quintana E, Shackleton M, Foster HR, Fullen DR,
Sabel MS, Johnson TM, et al. Phenotypic
heterogeneity among tumorigenic melanoma cells
from patients that is reversible and not hierarchically
organized. Cancer Cell. 2010 Nov 16;18(5):510-23.
33. Quintana E, Shackleton M, Sabel MS, Fullen DR,
Johnson TM, Morrison SJ. Efficient tumour formation
by single human melanoma cells. Nature. 2008 Dec
4;456(7222):593-8.
34. Chaffer CL, Marjanovic ND, Lee T, Bell G, Kleer
CG, Reinhardt F, et al. Poised chromatin at the ZEB1
@Real Academia Nacional de Farmacia. Spain